Ardelyx Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARDELYX INC, and what generic alternatives to ARDELYX INC drugs are available?
ARDELYX INC has two approved drugs.
There are seven US patents protecting ARDELYX INC drugs.
There are seventy-six patent family members on ARDELYX INC drugs in twenty-eight countries.
Summary for Ardelyx Inc
| International Patents: | 76 |
| US Patents: | 7 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Ardelyx Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ardelyx Inc | XPHOZAH | tenapanor hydrochloride | TABLET;ORAL | 213931-002 | Oct 17, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 9,408,840 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ardelyx Inc | XPHOZAH | tenapanor hydrochloride | TABLET;ORAL | 213931-001 | Oct 17, 2023 | DISCN | Yes | No | 10,272,079 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ardelyx Inc | XPHOZAH | tenapanor hydrochloride | TABLET;ORAL | 213931-003 | Oct 17, 2023 | RX | Yes | Yes | 10,272,079 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
